-+ 0.00%
-+ 0.00%
-+ 0.00%

3 Defensive Dividend Stocks Facing Higher Rates And $100 Oil

Simply Wall St·09/24/2026 06:29:14
Listen to the news

Bond yields are jumping, rate expectations are hardening, and oil above $100 is squeezing the weakest links first. Income investors who rely on dividends suddenly face a harsher test of which payouts might endure tighter money and higher input costs. This piece explains how that backdrop affects different sectors and highlights 3 high-dividend stocks from the Defensive High-Dividend Value Stocks screener that appear especially exposed to these cross-currents.

The three dividend stocks covered below are only a starter set from this tougher rate and energy backdrop. The full Defensive High-Dividend Value Stocks screen surfaced 8 more companies with equally compelling income stories that are not unpacked here. To identify and analyze the ideas that best match your own risk and yield targets, head straight into the Defensive High-Dividend Value Stocks screener.

McCormick (MKC)

Overview: McCormick is a global consumer staples company that supplies herbs, spices, seasonings, condiments, and flavor solutions to households and food businesses worldwide.

Operations: McCormick generates about US$4.4b in Consumer segment revenue and US$3.0b from Flavor Solutions, with additional sales across EMEA markets.

Market Cap: US$13.3b

For income investors, McCormick brings classic consumer staples resilience to a backdrop of higher rates and higher oil prices, which aligns with what this defensive high-dividend screen is designed to surface.

"Sustained volume-led growth, especially in the Consumer segment, is still tied to ongoing investments in brand marketing, product innovation focused on health, wellness, and convenience, and broader distribution. Ongoing global expansion and success in securing new customers in health oriented categories, particularly in Asia Pacific and in partnership with beverage and snack brands, continue to widen McCormick’s addressable market and diversify revenue streams."

What matters for McCormick now is how one unresolved pressure shapes the balance between strong cash generation and future earnings power.

That trade off sits at the center of the full narrative for McCormick, where McCormick’s income story, pricing power, and capital allocation choices stop being assumptions and start getting tested.

NYSE:MKC Earnings & Revenue History as at Sep 2026
NYSE:MKC Earnings & Revenue History as at Sep 2026

CVS Health (CVS)

Overview: CVS Health is a US-based healthcare group that combines insurance, pharmacy benefit management, and nationwide retail pharmacies to deliver integrated care.

Operations: CVS Health generates about US$200.5b from Health Services, US$143.8b from Health Care Benefits, and US$139.7b from Pharmacy & Consumer Wellness, all in the United States.

Market Cap: US$111.4b

CVS Health fits the Defensive High-Dividend Value Stocks theme as a large, cash-generative healthcare operator that links insurance, pharmacy benefits, and local drugstores into one income-oriented platform. This can be particularly relevant when higher rates pressure more cyclical dividend payers.

Recent setbacks have made CVS Health appear messy on the surface. At the same time, the restructuring and cost decisions that affected near-term results are also intended to refocus the business on steadier, higher-quality earnings that matter for long-term dividend reliability.

"The decline is contributed largely to a $1.1 billion charge connected with its Medicare and Individual Exchange businesses and a whopping $1.2 billion restructuring charge for store closures."

For income-focused investors, an important consideration is how this reset changes the balance between pressured healthcare margins and the cash supporting CVS Health’s future payouts.

That reset is the starting point for the full narrative for CVS Health, which unpacks how CVS Health’s earnings mix, cash generation, and risk profile could be quietly decoupling from today’s headline noise.

NYSE:CVS Revenue & Expenses Breakdown as at Sep 2026
NYSE:CVS Revenue & Expenses Breakdown as at Sep 2026

Stockland (ASX:SGP)

Overview: Stockland is an Australian property group that develops and manages residential communities, retail centres, and logistics and workplace assets nationwide.

Operations: Stockland generates about A$2.8b from Development activities and A$747 million from Investment Management across its Australian property portfolio.

Market Cap: A$10.2b

Stockland brings an income oriented, asset backed angle to this defensive high dividend screen, with bricks and mortar exposure that behaves differently to more rate sensitive growth stocks.

"Strong momentum in logistics development, including a $10bn pipeline and new data center joint venture with EdgeConneX, positions Stockland to capture tailwinds from the rise of e-commerce and demand for last-mile logistics, supporting rental growth, asset revaluations, and ultimately improved earnings and net asset value."

What really matters now is how one shift in where Stockland commits fresh capital influences both margin resilience and the steadiness of future distributions.

That capital shift is exactly what the full narrative for Stockland unpacks, explaining where Stockland’s growth engine may be accelerating and which risks might quietly be masking upside.

ASX:SGP Earnings & Revenue History as at Sep 2026
ASX:SGP Earnings & Revenue History as at Sep 2026

Seeking Fresh Alternatives Before They Fly

Markets move fast and the next breakout list will not stay under the radar for long. Scan these fresh ideas before the crowd catches on and act now.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.